Friday, July 10, 2026

pharma · No medical condition. · No medical condition

Tillomed Laboratories

Laboratorios Tillomed Spain is a pharma organization headquartered in EU. Primary therapeutic focus areas include No medical condition., No medical condition, Hormone receptor-positive early breast cancer in post-menopau

Luton, GB HQ
1 Employees
EMA registrant Type
Company details
Clinical program

Bioequivalence clinical trial of two formulations of dapagliflozin/metformin

Phase 1 · other · Healthy volunteers

Bioequivalence clinical trial of two formulations of dapagliflozin/metformin for Healthy volunteers is a Phase 1 program (other) at Laboratorios Tillomed Spain S.L.U with 1 ClinicalTrials.gov record(s).

Internal code N-DAPMET-24-284

Full intelligence profile for this program is being prepared.

At a glance

Sponsor
Laboratorios Tillomed Spain S.L.U
Phase
Phase 1
Modality
other
Indication
Healthy volunteers
Status
active
Trials
1